Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac myosin-binding protein-C phosphorylation and cardiac function.

Sakthivel Sadayappan1, James Gulick, Hanna Osinska

  • 1Division of Molecular Cardiovascular Biology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, OH, USA.

Circulation Research
|October 15, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thick filament molecular interfaces play a critical role in the pathogenesis of hypertrophic cardiomyopathy.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Apelin analog treatment reverses severe pulmonary arterial hypertension and right ventricular heart failure.

JCI insight·2026
Same author

Targeting Inflammation by Pioglitazone and its R-Enantiomer Mitigates Pathological Myocardial Remodeling in Murine Hypertrophic Cardiomyopathy.

JACC. Basic to translational science·2026
Same author

Integrative Molecular Analyses of Inflammatory and Autoimmune Signals in Cardiac Sarcoidosis.

Circulation·2026
Same author

Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe Registry.

Journal of the American College of Cardiology·2026
Same author

Rare <i>KDR</i> Variants Define a Distinct Genetic Contribution to Congenital Heart Disease.

Circulation. Genomic and precision medicine·2026

Cardiac myosin binding protein-C (cMyBP-C) phosphorylation is crucial for normal heart function. Reduced cMyBP-C phosphorylation contributes to heart failure, highlighting its essential role in cardiac physiology.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • The role of cardiac myosin binding protein-C (cMyBP-C) phosphorylation in cardiac health and disease remains largely unknown.
  • Understanding cMyBP-C phosphorylation is vital for elucidating mechanisms of cardiac dysfunction.

Purpose of the Study:

  • To investigate the in vivo phosphorylation status of cMyBP-C in stressed and unstressed mouse hearts.
  • To determine the functional consequences of altered cMyBP-C phosphorylation in transgenic mouse models.

Main Methods:

  • Assessed cMyBP-C phosphorylation levels in mouse hearts under varying physiological conditions.
  • Generated transgenic mice with nonphosphorylatable cMyBP-C mutations (MyBP-C(AllP-)).
  • Utilized breeding strategies to create models with partial and complete replacement of endogenous cMyBP-C.

Related Experiment Videos

Main Results:

  • cMyBP-C phosphorylation significantly decreases during heart failure and pathological hypertrophy.
  • Partial replacement with nonphosphorylatable cMyBP-C impaired cardiac contractility and induced hypertrophic gene expression.
  • Complete replacement with nonphosphorylatable cMyBP-C failed to rescue the MyBP-C(t/t) phenotype, leading to severe cardiac hypertrophy, disarray, and fibrosis.

Conclusions:

  • cMyBP-C phosphorylation is essential for maintaining normal cardiac contractility and sarcomeric structure.
  • Impaired cMyBP-C phosphorylation contributes to the pathophysiology of heart failure and cardiac hypertrophy.
  • These findings underscore the critical importance of cMyBP-C phosphorylation in cardiac physiology.